ProShare Advisors’s Castle Biosciences CSTL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-8,613
| Closed | -$230K | – | 2133 |
|
2024
Q4 | $230K | Buy |
+8,613
| New | +$230K | ﹤0.01% | 1818 |
|
2022
Q2 | – | Sell |
-6,625
| Closed | -$298K | – | 1861 |
|
2022
Q1 | $298K | Sell |
6,625
-1,593
| -19% | -$71.7K | ﹤0.01% | 1635 |
|
2021
Q4 | $352K | Buy |
8,218
+111
| +1% | +$4.75K | ﹤0.01% | 1690 |
|
2021
Q3 | $539K | Sell |
8,107
-1,924
| -19% | -$128K | ﹤0.01% | 1164 |
|
2021
Q2 | $736K | Buy |
10,031
+2,758
| +38% | +$202K | ﹤0.01% | 1241 |
|
2021
Q1 | $498K | Buy |
7,273
+1,573
| +28% | +$108K | ﹤0.01% | 1441 |
|
2020
Q4 | $383K | Buy |
5,700
+1,091
| +24% | +$73.3K | ﹤0.01% | 1429 |
|
2020
Q3 | $237K | Buy |
+4,609
| New | +$237K | ﹤0.01% | 1326 |
|